Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 2 things

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Jan 28, 2024 6:17pm

217 Views

Post# 35849632

RE:RE:RE:RE:2 things

I don't think anything big will happen on the JV front untiil BTD which is what TLT is working on now. New unapproved tech needs BTD as a derisking factor before a big company is going to pile in. I suspect the shorting is hedge fund driven and simple profiteering on an easy target. BTD within a few months I hope. Followed by institutional investment that if there is any justice, cleans out a shorters account or two. JV by fall. All just my hopeful guess.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?